Metavas MR 35 mg (Tablet (Modified Release))

Unit Price: ৳ 8.00 (6 x 10: ৳ 480.00)
Strip Price: ৳ 80.00

Medicine Details

Category Details
Generic Trimetazidine dihydrochloride
Company Nipro jmi pharma ltd

Indications

  • Add-on therapy for stable angina pectoris

Pharmacology

  • First 3- keto acyl CoA thiolase inhibitor
  • Metabolic anti-ischemic agent
  • Inhibits fatty acid pathway
  • Transfers oxygen to glucose pathway
  • Prevents angina pectoris

Dosage & Administration

  • Recommended dose: 35 mg twice daily or 20 mg tablet thrice daily during meals
  • Assessment of treatment response after three months
  • Discontinue if no treatment response

Interaction

  • No reported drug interactions with beta-blockers, calcium antagonists, nitrates, heparin, hypolipidemic agents, or digitalis preparation

Contraindications

  • Hypersensitivity to active substance or excipients
  • Parkinson’s disease or symptoms, tremors, restless legs movement disorders, severe renal impairment

Side Effects

  • Common side effects: dizziness, headache, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, rash, pruritus, urticaria, asthenia

Pregnancy & Lactation

  • Preferable to avoid use during pregnancy
  • Unknown excretion in human milk
  • Risk to newborns/infants cannot be excluded
  • Should not be used during breastfeeding

Precautions & Warnings

  • Not a curative treatment for angina attacks
  • Not an initial treatment for unstable angina pectoris
  • Not a treatment for myocardial infarction

Therapeutic Class

  • Other Anti-anginal & Anti-ischaemic drugs

Storage Conditions

  • Keep in a dry place away from light and heat
  • Keep out of the reach of children

Related Brands